Maison Luxe, Inc ($MASN)

$MASN | Public Company | Official account of Maison Luxe, Inc. (OTC:MASN) Corporate updates, company progress, and shareholder information.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

$MASN Update: Maison Luxe, Inc. expands its strategic corporate review to include AI-enabled business opportunities, targeting companies integrating intelligent automation to scale operations.

Full press release: https://t.co/Q0fBMgVaE8

#ArtificialIntelligence #CorporateDevelopment #Stocks #M&A #PennyStocks

[Maison Luxe, Inc ($MASN) @MASN_Inc]

At $MASN, we’re looking ahead. We are actively exploring and evaluating opportunities in innovative, AI-oriented businesses that drive sustainable growth and long-term value creation.

The future is intelligent. Let’s build it. 🚀

#Innovation #AI #StrategicGrowth #VentureCapital

[Maison Luxe, Inc ($MASN) @MASN_Inc]

$MASN Management continues to spend considerable time evaluating opportunities that complement our long-term strategy. Sometimes the most valuable opportunities are about finding businesses where innovation creates lasting value.

Have a great weekend.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Strategic update from Maison Luxe, Inc. ($MASN) - Due diligence is actively underway for two targeted health and wellness acquisitions to drive long-term shareholder value.

Stay updated: https://t.co/c5Pg5gkz0k

#StocksToWatch #OTCBulletin #MergersAndAcquisitions

[Maison Luxe, Inc ($MASN) @MASN_Inc]

We understand the concern around share structure and appreciate shareholders staying engaged.

The increase you’re referencing reflects shares that have been issued in accordance with previously disclosed corporate actions, financing arrangements, and conversions that have been properly filed. These changes are part of the ongoing updates that flow through the transfer agent and are then reflected in the OTC Markets system once processed.

At this time, all activity has been handled through the appropriate channels and filings, and there is no “unreported” issuance outside of what has already been disclosed.

The share structure on OTC Markets is updated based on those filings and processing timelines, so there can be a lag between issuance activity and what is displayed publicly.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Maison Luxe Inc. (OTC: MASN) has appointed Robert Roever as Interim President, Secretary, Treasurer & Director.

The Company continues to review strategic opportunities across health & wellness, energy, consumer products, specialty products and other growth-oriented sectors.

The Company has not entered into any definitive agreement at this time.

https://t.co/s8lNnwuAbU

[Maison Luxe, Inc ($MASN) @MASN_Inc]

All required filings and updates have been submitted to OTC Markets for review and processing. Once OTC Markets completes its review and grants approval, the change in control and related updates will be reflected on the OTC Markets platform.

Regarding timing, OTC Markets operates on its own review schedule, so we do not have control over or a precise date for when the updates will be posted. However, once approval is granted, the changes are typically reflected shortly thereafter.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

UPDATE
Full release link here: https://t.co/dOJsOpJznC

[Maison Luxe, Inc ($MASN) @MASN_Inc]

$MASN MAISON LUXE INC. Announces Management Transition and Appointment of New Management

Full press release here: https://t.co/jHVjUch5J4

[Maison Luxe, Inc ($MASN) @MASN_Inc]

@nash_gomez We appreciate the continued engagement. The Company remains focused on advancing its strategic initiatives and will provide updates through appropriate channels as developments occur.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

EU-GMP certification, the same standard applied to conventional pharmaceutical production, is increasingly becoming the baseline requirement for market access across European medical cannabis jurisdictions.

For producers, compliance is the entry ticket.

For the market, certified infrastructure is the differentiator that separates scalable operations from those that cannot grow.

$MASN

#PharmaCannabis #EUGMP #MedicalCannabis #CannabisInvesting #CannabisIndustry

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Germany imports the vast majority of its medical cannabis supply. Poland imports nearly all of it. The UK remains heavily import-dependent.

This structural supply deficit, across Europe's largest patient markets, defines the opportunity for compliant international producers with licensed cultivation and processing capacity

$MASN

#MedicalCannabis #EuropeanMarkets #CannabisIndustry #EuropeanCannabis #SupplyChain

[Maison Luxe, Inc ($MASN) @MASN_Inc]

@TraderMip We appreciate the feedback and understand shareholders are looking for meaningful progress updates. Our focus remains on continuing to build the company and communicating developments as they become appropriate to share.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

🇵🇱 Poland - with a population exceeding 38 million - is one of the fastest-growing medical cannabis patient markets in Europe.

Despite currently relying almost entirely on imported product, the government has signalled openness to expanding its domestic cultivation framework.

Supply gaps of this scale attract serious capital attention

$MASN

#Poland #EuropeanCannabis #MedicalCannabis #EuropeanMarkets #CannabisInvesting

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Beyond the capital markets narrative, regulated cannabis cultivation represents a meaningful economic driver for the regions it operates in.

Licensed greenhouse operations generate skilled agricultural employment, stimulate local supply chains, and contribute to export revenues, making them an attractive proposition for governments looking to develop their agricultural sectors

$MASN

#Cannabis #Agriculture #EuropeanMarkets #CannabisIndustry #EconomicDevelopment

[Maison Luxe, Inc ($MASN) @MASN_Inc]

One of the most persistent challenges facing the North American cannabis sector is access to institutional banking and traditional capital markets.

In Europe, medical cannabis companies operating within EU-regulated frameworks face considerably fewer financial restrictions, enabling more conventional capital formation and broader institutional participation
$MASN

#MedicalCannabis #CannabisInvesting #EuropeanMarkets #OTCMarkets #InvestorRelations

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Controlled-environment greenhouse cultivation offers more than compliance advantages.

Compared to open-field farming, modern greenhouse cannabis operations deliver significantly reduced water consumption, lower pesticide application, and year-round production consistency, making them the preferred model for pharmaceutical-grade output in regulated European market

$MASN

#Cultivation #Cannabis #Agriculture #SustainableAgriculture #MedicalCannabis

[Maison Luxe, Inc ($MASN) @MASN_Inc]

@nash_gomez The Company continues to advance its strategic initiatives and evaluate opportunities aligned with its long-term growth plan. Updates will be shared through appropriate channels as developments occur. Thank you for your interest.

[Maison Luxe, Inc ($MASN) @MASN_Inc]

Maison Luxe (OTC: $MASN) signs term sheet with a private acquisition target🤝

Our team continues to evaluate domestic & international opportunities with operational substance and long-term value potential.

#LuxuryRetail #MASN

[Maison Luxe, Inc ($MASN) @MASN_Inc]

The European medical cannabis supply chain is still maturing and that creates a structural opportunity.

Countries with licensed cultivation capacity, processing infrastructure, and access to regulated distribution networks are positioned to become the primary suppliers to markets where domestic production cannot yet meet demand.

$MASN

#MedicalCannabis #CannabisIndustry #EuropeanMarkets #SupplyChain #CannabisInvesting

[Maison Luxe, Inc ($MASN) @MASN_Inc]

🇵🇹 Portugal was among the first European nations to establish a legal medical cannabis framework, with cultivation and export licensing introduced as early as 2018.

Its Atlantic climate, established agricultural export infrastructure, and competitive operational costs have positioned it as a reference market for European cannabis production

$MASN

#Portugal #EuropeanCannabis #MedicalCannabis #Cultivation #EuropeanMarkets